ActiveGRANT
DoW Autism Clinical Trial Award
Department of DefenseDept. of the Army -- USAMRAA
AI Overview
Support clinical trials evaluating new treatments, devices, and approaches for autism management. Awards fund proof-of-concept through large-scale efficacy studies, with funding incentives for early-career researchers partnering with experienced mentors.
This summary is AI-generated from the official solicitation.
Key Details
Agency
Department of Defense
Funding Amount
—
Release Date
May 21, 2026
Due Date
October 22, 2026
Official Description
<p><strong>Summary: </strong>The fiscal year 2026 (FY26) Autism Research Program (ARP) Clinical Trial Award supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of autism. Clinical trials may be designed to evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e....
View on official sourceChange History
Opportunity AddedMay 21, 2026 at 9:07 PM
DoW Autism Clinical Trial Award
New Grants.gov opportunity: DoW Autism Clinical Trial Award
Get Alerts for Opportunities Like This
RallyProp monitors thousands of funding sources and sends instant alerts when opportunities match your technology and capabilities.
Start Free Trial